Labcorp Holdings Inc. (LH) Stock
NASDAQ · LH
309.73
Fundamentals
Market cap
$25.11B
Price / Earnings ratio
25.0x
Price / Sales ratio
1.8x
Price / Book ratio
2.9x
Return on assets
5.0%
Ex-Dividend date
28 Aug 2026
Last payment date
11 Sep 2026
Dividend amount
$0.72
Dividend yield
0.93%
Debt / Equity ratio
N/A
Recent news

The Motley Fool
Why Labcorp Holdings Stock Dropped Today
NeutralLHSeptember 22, 2026
The Motley FoolNeutral
Why Labcorp Holdings Stock Dropped Today
LH

Business Wire
Great Point Partners III Sells MLM Medical Labs to Labcorp
NeutralLHSeptember 9, 2026
Business WireNeutral
Great Point Partners III Sells MLM Medical Labs to Labcorp
LH

Zacks Investment Research
Why Labcorp Holdings (LH) is a Top Value Stock for the Long-Term
NeutralLHSeptember 7, 2026
Zacks Investment ResearchNeutral
Why Labcorp Holdings (LH) is a Top Value Stock for the Long-Term
LH

Zacks Investment Research
Here's Why Labcorp Holdings (LH) is a Strong Momentum Stock
NeutralLHSeptember 2, 2026
Zacks Investment ResearchNeutral
Here's Why Labcorp Holdings (LH) is a Strong Momentum Stock
LH
Technicals
OscillatorsSell5 Indicators
Moving AveragesSell12 Indicators
Analyst Ratings
Strong Sell0
Sell0
Neutral3
Buy6
Strong Buy0
Financials
Performance
Revenue
Net income
Net margin %
2021
2022
2023
2024
2025
19B13B6B0
Debt & Balance Sheet
Total assets
Total liabilities
2021
2022
2023
2024
2025
24B16B8B0
Revenue to Profit
2025$14.0B
Revenue$0.0
Cost of revenue$0.0
Gross profit$0.0
Operating expenses$876.5M
Net incomeEarnings
EPS forecast
Actual EPS
$3.84
$4.17
Q1FY25
$4.35
$4.15
Q2FY25
$4.18
$4.13
Q3FY25
$3.94
Q4FY25
$4.10
Q1FY26
The market is expecting earnings per share of $4.10 for this quarter. The company has not yet shared when it is announcing earnings.
% positive news of 10 articles
published over the past 14 days
Latest news

The Motley Fool
Why Labcorp Holdings Stock Dropped Today
NeutralLHSeptember 22, 2026
The Motley FoolNeutral
Why Labcorp Holdings Stock Dropped Today
LH

Business Wire
Great Point Partners III Sells MLM Medical Labs to Labcorp
NeutralLHSeptember 9, 2026
Business WireNeutral
Great Point Partners III Sells MLM Medical Labs to Labcorp
LH

Zacks Investment Research
Why Labcorp Holdings (LH) is a Top Value Stock for the Long-Term
NeutralLHSeptember 7, 2026
Zacks Investment ResearchNeutral
Why Labcorp Holdings (LH) is a Top Value Stock for the Long-Term
LH

Zacks Investment Research
Here's Why Labcorp Holdings (LH) is a Strong Momentum Stock
NeutralLHSeptember 2, 2026
Zacks Investment ResearchNeutral
Here's Why Labcorp Holdings (LH) is a Strong Momentum Stock
LH

Zacks Investment Research
Should You Continue to Hold Labcorp Stock in Your Portfolio?
NeutralLHAugust 25, 2026
Zacks Investment ResearchNeutral
Should You Continue to Hold Labcorp Stock in Your Portfolio?
LH

The Motley Fool
Labcorp CEO Adam Schechter Sells 4,669 Shares for $1.5 Million
NeutralLHAugust 12, 2026
The Motley FoolNeutral
Labcorp CEO Adam Schechter Sells 4,669 Shares for $1.5 Million
LH

Zacks Investment Research
Is Labcorp Stock a Buy as Growth Improves but Valuation Stays Rich?
NeutralLHAugust 10, 2026
Zacks Investment ResearchNeutral
Is Labcorp Stock a Buy as Growth Improves but Valuation Stays Rich?
LH

Zacks Investment Research
Here's Why Labcorp Holdings (LH) is a Strong Momentum Stock
NeutralLHAugust 10, 2026
Zacks Investment ResearchNeutral
Here's Why Labcorp Holdings (LH) is a Strong Momentum Stock
LH

Zacks Investment Research
Labcorp Stock Jumps 14% in a Month as Growth Meets Rich Valuation
NeutralLHAugust 7, 2026
Zacks Investment ResearchNeutral
Labcorp Stock Jumps 14% in a Month as Growth Meets Rich Valuation
LH

Zacks Investment Research
Here's Why Labcorp Holdings (LH) is a Strong Value Stock
NeutralLHAugust 4, 2026
Zacks Investment ResearchNeutral
Here's Why Labcorp Holdings (LH) is a Strong Value Stock
LH
About Labcorp Holdings Inc.
Labcorp is a leading global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. Through our unparalleled diagnostics and drug development capabilities, we provide insights and accelerate innovations to improve health and save lives.
SectorHealthcare
IndustryDiagnostics & Research
Employees71,000
CEOMr. Adam H. Schechter
IPO DateMar 29, 1990
HeadquartersBurlington, NC
Key Executives
| Name | Title | Year Born |
|---|---|---|
| Mr. Adam H. Schechter | President, CEO & Chairman | 1965 |
| Ms. Julia A. Wang | CFO & Executive VP | 1972 |
| Dr. Brian J. Caveney J.D., M.D., M.P.H. | Exec VP, President of Biopharma Laboratory Services & Chief Medical and Scientific Officer | 1974 |
| Mr. Jonathan C. Meltzer Ph.D. | EVP & Chief Operations Officer | — |
| Mr. Peter J. Wilkinson | Senior VP & Chief Accounting Officer | 1971 |
| Mr. Akinbolade Oyegunwa M.B.A., Ph.D. | Executive VP and Chief Information & Technology Officer | 1983 |
| Mr. Dewey Steadman C.F.A. | Senior Vice President of Investor Relations | — |
| Ms. Kathryn Wright Kyle | Executive VP, Chief Legal Officer and Corporate Secretary | 1971 |
| Ms. Amy B. Summy | EVP, Chief Marketing Officer & Consumer Health Lead | 1966 |
| Ms. Anita Z. Graham | Executive VP & Chief Human Resources Officer | 1971 |
Fundamentals
Valuation
Market cap$25.11B
Price-to-sales ratio1.75
Price-to-book value2.91
Price-earnings ratio25.00
Return on Equity11.00%
Return on Sales10.00%
Return on Assets5.00%
PEG ratio1.21
Earnings Per Share
Earnings Per Share$12.17
Income Statement
Average volume806,443
EBITDA$2.27B
1 year high (52w)$341.80
1 year low (52w)$244.52
Dividend
Ex dividend date28 Aug 2026
Dividend amount$0.72
Dividend yield0.93%
Last payment date11 Sep 2026
Dividend yield (TTM)0.93%
Next earnings reportN/A
Solvency
Debt-to-equity ratioN/A
Technicals
OscillatorsSell5 Indicators
Moving AveragesSell12 Indicators
What the experts say
9 Wall Street Analyst Ratings
BUY
67% Buy
33% Hold
0% Sell
Target price
$340.00
Est return
9.80%
Seasonality
Monthly price change (%)| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021 | -1.9 | +2.7 | -1.2 | +10.1 | ||||||||
| 2022 | -9.0 | -0.6 | -2.0 | -8.7 | +1.5 | -4.6 | +8.8 | -12.7 | -9.8 | +4.7 | +8.2 | -2.6 |
| 2023 | +6.0 | -4.3 | -3.6 | -1.6 | -7.5 | +13.6 | +2.4 | -2.6 | -2.7 | +0.1 | +6.4 | +3.8 |
| 2024 | -4.4 | -3.8 | +0.2 | -6.9 | -3.2 | +4.4 | +6.1 | -1.5 | -2.7 | +4.1 | +6.2 | -4.7 |
| 2025 | +9.5 | +1.3 | -8.4 | +3.6 | +3.2 | +5.9 | -1.6 | +6.3 | +4.9 | -9.0 | +4.2 | -6.3 |
| 2026 | +7.9 | +7.0 | -6.9 | -5.8 | +1.6 | +9.0 | +8.9 | +8.2 | -5.5 |
Corporate actions
Upcoming
No upcoming corporate actions for LH
Past
DividendQ3/26
Ex-dividend date28 Aug 2026
Payable date11 Sep 2026
Amount per share$0.72
DividendQ2/26
Ex-dividend date29 May 2026
Payable date11 Jun 2026
Amount per share$0.72
DividendQ1/26
Ex-dividend date27 Feb 2026
Payable date12 Mar 2026
Amount per share$0.72
DividendQ4/25
Ex-dividend date26 Nov 2025
Payable date11 Dec 2025
Amount per share$0.72
DividendQ3/25
Ex-dividend date28 Aug 2025
Payable date11 Sep 2025
Amount per share$0.72
DividendQ2/25
Ex-dividend date29 May 2025
Payable date11 Jun 2025
Amount per share$0.72
DividendQ1/25
Ex-dividend date27 Feb 2025
Payable date12 Mar 2025
Amount per share$0.72
DividendQ4/24
Ex-dividend date26 Nov 2024
Payable date13 Dec 2024
Amount per share$0.72
DividendQ3/24
Ex-dividend date29 Aug 2024
Payable date13 Sep 2024
Amount per share$0.72
DividendQ2/24
Ex-dividend date24 May 2024
Payable date12 Jun 2024
Amount per share$0.72
DividendQ1/24
Ex-dividend date26 Feb 2024
Payable date13 Mar 2024
Amount per share$0.72
DividendQ4/23
Ex-dividend date7 Nov 2023
Payable date12 Dec 2023
Amount per share$0.72
DividendQ3/23
Ex-dividend date7 Aug 2023
Payable date8 Sep 2023
Amount per share$0.72
DividendQ2/23
Ex-dividend date17 May 2023
Payable date8 Jun 2023
Amount per share$0.72
DividendQ1/23
Ex-dividend date22 Feb 2023
Payable date13 Mar 2023
Amount per share$0.72
DividendQ4/22
Ex-dividend date16 Nov 2022
Payable date9 Dec 2022
Amount per share$0.72
DividendQ3/22
Ex-dividend date17 Aug 2022
Payable date9 Sep 2022
Amount per share$0.72
DividendQ2/22
Ex-dividend date18 May 2022
Payable date9 Jun 2022
Amount per share$0.72



